Chlamydophila pneumoniae (ATCC® VR-1356™)

Classification: Chlamydiacea, Chlamydophila  /  Product Format: frozen

Permits Notice: Necessary Permits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Classification Chlamydiacea, Chlamydophila
Agent Chlamydophila pneumoniae
Strain TWAR strain 2023
Applications
Respiratory research
Biosafety Level 2
Isolation
nasopharynx of human patient with pneumonia
Product Format frozen
Storage Conditions -70°C or colder
Comments
This preparation has tested positive for Mycoplasma contamination.
Note that activities with high potential for aerosol production require BSL 3 facilities and practices.
Forms intracellular inclusions which react with specific anti-C. pneumoniae monoclonal antibodies and monoclonal antibodies directed against the chlamydia LPS.
Inclusions will not stain with iodine or monoclonal antibodies against the MOMP of C. trachomatis. Infection is enhanced by centrifugation and use of cycloheximide (1 to 2 mcg/ml) in medium.
Suggested protocol for propagation: Add glass beads and vortex preparation to disrupt cells. Infect monolayer with disrupted material. Centrifuge at 3000 x rpm (750 x g) for 1 hour.
Feed with fresh growth medium containing FBS prescreened for Chlamydia antibodies and 1-2 ug/mL cycloheximide. Incubate at 37°C for 72 hours.
-70°C or colder
Infection is enhanced by centrifugation and use of cycloheximide (1 to 2 mcg/ml) in medium.
Effect on Host
Intracellular inclusion bodies visualized by fluorescent staining with genus or species specific conjugated antibodies
Recommended Host
HEp-2 cells (ATCC CCL-23)
Human; human cell lines; HeLa 229 cells (ATCC CCL-2.1)
Growth Conditions
Incubation: 2-3 days at 37°C in HEp-2 cells (ATCC CCL-23)
Cryopreservation
Storage temperature: -70C or lower
Effect on Host
Intracellular inclusion bodies visualized by fluorescent staining with genus or species specific conjugated antibodies
Name of Depositor MR Hammerschlag
Source
nasopharynx of human patient with pneumonia
References

Chirgwin K, et al. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR). Antimicrob. Agents Chemother. 33: 1634-1635, 1989. PubMed: 2817862

Permits Notice: Necessary Permits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
Product Sheet
Product Sheet
Certificate of Analysis
Certificate of Analysis
MSDS
MSDS